TABLE 4.
Statin Dose Intensity Before and After 2013 Cholesterol Guidelinea
| Preguideline | Postguideline | Change | Std. Diff. (%)b | |
| ASCVD, ≥75 years (n = 87,519) | ||||
| None | 11,010 (12.6) | N/A | N/A | N/A |
| Low | 13,932 (15.9) | 15,090 (17.2) | 1,158 (1.3) | 3.5 |
| Moderate | 48,943 (55.9) | 54,578 (62.4) | 5,635 (6.4) | 13.3 |
| High | 13,634 (15.6) | 17,851 (20.4) | 4,217 (4.8) | 12.5 |
| ASCVD, > 75 years (n = 54,998) | ||||
| None | 5,501 (10.0) | N/A | N/A | N/A |
| Low | 11,248 (20.5) | 12,302 (22.4) | 1,054 (1.9) | 4.6 |
| Moderate | 32,210 (58.6) | 35,230 (64.1) | 3,020 (5.5) | 11.3 |
| High | 6,039 (11.0) | 7,466 (13.6) | 1,427 (2.6) | 7.9 |
| Moderate or high | 38,249 (69.5) | 42,696 (77.6) | 4,447 (8.1) | 18.4 |
| DM (n = 159,195) | ||||
| None | 22,876 (14.4) | N/A | N/A | N/A |
| Low | 29,451 (18.5) | 32,687 (20.5) | 3,236 (2.0) | 5.0 |
| Moderate | 89,877 (56.5) | 102,576 (64.4) | 12,699 (8.0) | 16.2 |
| High | 16,991 (10.7) | 23,932 (15.0) | 6,941 (4.4) | 12.9 |
| Moderate or high | 106,868 (67.1) | 126,508 (79.5) | 19,640 (12.3) | 28.3 |
Note: Values are represented as number (%) unless noted otherwise.
a Rates are aggregate rates and are restricted to only those patients who were on statin therapy 1 year after the 2013 cholesterol guideline.
b A standardized difference of >10% was considered a significant imbalance between proportions.
ASCVD = atherosclerotic cardiovascular disease; DM = diabetes mellitus; N/A = not applicable; Std. Diff. = standardized difference.